Ambit Biosciences Secures $64,800,000 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ce8fb9cb-b82a-4fa0-8336-60969f1d2930&Preview=1 - Date
5/16/2013 - Company Name
Ambit Biosciences - Mailing Address
4215 Sorrento Valley Blvd. San Diego, CA 92121 - Company Description
Ambit Biosciences (NASDAQ: AMBI) is a privately-held biopharmaceutical company engaged in the discovery and development of small-molecule kinase inhibitors for the treatment of cancer. - Website
http://www.ambitbio.com - Transaction Type
IPO - Transaction Amount
$64,800,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes are on file with company statements at the SEC. - M&A Terms
